Lila Biologics hopes to hand off a candidate protein within three to six months so the pharmaceutical giant can take the drug through clinical trials. Read More
Researchers at Seattle’s Fred Hutchinson Cancer Research Center have demonstrated the effectiveness of a new method for getting immune cells… Read More
Seattle-based biotech startup Kineta today received a leg-up in its efforts to kill cancerous tumors using the immune system. Kineta announced an… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.
